Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Blood ; 134(17): 1469-1479, 2019 10 24.
Artículo en Inglés | MEDLINE | ID: mdl-31501155

RESUMEN

Fluid shear stress in the vasculature is the driving force for natural bypass growth, a fundamental endogenous mechanism to counteract the detrimental consequences of vascular occlusive disease, such as stroke or myocardial infarction. This process, referred to as "arteriogenesis," relies on local recruitment of leukocytes, which supply growth factors to preexisting collateral arterioles enabling them to grow. Although several mechanosensing proteins have been identified, the series of mechanotransduction events resulting in local leukocyte recruitment is not understood. In a mouse model of arteriogenesis (femoral artery ligation), we found that endothelial cells release RNA in response to increased fluid shear stress and that administration of RNase inhibitor blocking plasma RNases improved perfusion recovery. In contrast, treatment with bovine pancreatic RNase A or human recombinant RNase1 interfered with leukocyte recruitment and collateral artery growth. Our results indicated that extracellular RNA (eRNA) regulated leukocyte recruitment by engaging vascular endothelial growth factor receptor 2 (VEGFR2), which was confirmed by intravital microscopic studies in a murine cremaster model of inflammation. Moreover, we found that release of von Willebrand factor (VWF) as a result of shear stress is dependent on VEGFR2. Blocking VEGFR2, RNase application, or VWF deficiency interfered with platelet-neutrophil aggregate formation, which is essential for initiating the inflammatory process in arteriogenesis. Taken together, the results show that eRNA is released from endothelial cells in response to shear stress. We demonstrate this extracellular nucleic acid as a critical mediator of mechanotransduction by inducing the liberation of VWF, thereby initiating the multistep inflammatory process responsible for arteriogenesis.


Asunto(s)
Células Endoteliales/metabolismo , Mecanotransducción Celular , Neovascularización Fisiológica , ARN/metabolismo , Estrés Mecánico , Animales , Arterias/fisiología , Bovinos , Células Cultivadas , Células Endoteliales/citología , Ratones , Ratones Endogámicos C57BL
2.
Eur Arch Otorhinolaryngol ; 275(2): 515-524, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29204919

RESUMEN

OBJECTIVE: Lymph node ratio (LNR) was shown to be a prognostic factor in laryngeal and oral cavity primaries. The purpose of this study was to investigate the impact of the lymph node ratio in oropharyngeal squamous cell carcinoma (OPSCC) with a high incidence of HPV-related disease. Therefore, the role of LNR was evaluated as an additional predictive parameter to the 8th edition of AJCC TNM staging system. METHODS: From December 2009 to August 2015, patients diagnosed with primary oropharyngeal squamous cell carcinoma were prospectively enrolled. After tumor resection with uni- or bilateral neck dissection, patients with ≥ 1 nodal metastasis (pN+) were eligible for a retrospective LNR analysis. RESULTS: 137 patients underwent tumor resection with uni- or bilateral neck dissection. The proportion of HPV-associated disease was 42%. Most patients (n = 96; 70%) presented with involved neck nodes. In p16-positive OPSCC, the rate of pN + cases was significantly increased compared to p16-negative OPSCC (86% vs. 58%, p = 0.007). Patients with LNR ≤ 10% had a significant better overall survival (OS) and disease-specific survival (DSS). However, when stratified for p16-status, LNR ≤ 10% had a significant impact on OS only for HPV-associated tumors (p = 0.027), whereas LNR of ≤ 10% was not a significant predictor for better OS in p16-negative OPSCC (p = 0.143). CONCLUSION: The LNR with a cut-off value of 10% serves as an additional prognostic parameter in HPV-related OPSCC and may help to improve risk stratification in combination with the revised AJCC 8th edition TNM classification.


Asunto(s)
Carcinoma de Células Escamosas/patología , Ganglios Linfáticos/patología , Estadificación de Neoplasias/métodos , Neoplasias Orofaríngeas/patología , Infecciones por Papillomavirus/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/mortalidad , Carcinoma de Células Escamosas/cirugía , Carcinoma de Células Escamosas/virología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Cuello/patología , Disección del Cuello , Neoplasias Orofaríngeas/mortalidad , Neoplasias Orofaríngeas/cirugía , Neoplasias Orofaríngeas/virología , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Análisis de Supervivencia
3.
EBioMedicine ; 27: 237-246, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29233575

RESUMEN

Midkine is a pleiotropic factor, which is involved in angiogenesis. However, its mode of action in this process is still ill defined. The function of midkine in arteriogenesis, the growth of natural bypasses from pre-existing collateral arteries, compensating for the loss of an occluded artery has never been investigated. Arteriogenesis is an inflammatory process, which relies on the proliferation of endothelial cells and smooth muscle cells. We show that midkine deficiency strikingly interferes with the proliferation of endothelial cells in arteriogenesis, thereby interfering with the process of collateral artery growth. We identified midkine to be responsible for increased plasma levels of vascular endothelial growth factor A (VEGFA), necessary and sufficient to promote endothelial cell proliferation in growing collaterals. Mechanistically, we demonstrate that leukocyte domiciled midkine mediates increased plasma levels of VEGFA relevant for upregulation of endothelial nitric oxide synthase 1 and 3, necessary for proper endothelial cell proliferation, and that non-leukocyte domiciled midkine additionally improves vasodilation. The data provided on the role of midkine in endothelial proliferation are likely to be relevant for both, the process of arteriogenesis and angiogenesis. Moreover, our data might help to estimate the therapeutic effect of clinically applied VEGFA in patients with vascular occlusive diseases.


Asunto(s)
Arteria Femoral/crecimiento & desarrollo , Arteria Femoral/metabolismo , Péptidos y Proteínas de Señalización Intercelular/farmacología , Óxido Nítrico Sintasa/metabolismo , Organogénesis/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/metabolismo , Animales , Disponibilidad Biológica , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/metabolismo , Proliferación Celular/efectos de los fármacos , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Arteria Femoral/efectos de los fármacos , Leucocitos/efectos de los fármacos , Leucocitos/metabolismo , Ratones Endogámicos C57BL , Midkina , Modelos Biológicos , Compuestos Nitrosos/farmacología
4.
Cell Rep ; 16(8): 2197-2207, 2016 08 23.
Artículo en Inglés | MEDLINE | ID: mdl-27524614

RESUMEN

The body has the capacity to compensate for an occluded artery by creating a natural bypass upon increased fluid shear stress. How this mechanical force is translated into collateral artery growth (arteriogenesis) is unresolved. We show that extravasation of neutrophils mediated by the platelet receptor GPIbα and uPA results in Nox2-derived reactive oxygen radicals, which activate perivascular mast cells. These c-kit(+)/CXCR-4(+) cells stimulate arteriogenesis by recruiting additional neutrophils as well as growth-promoting monocytes and T cells. Additionally, mast cells may directly contribute to vascular remodeling and vascular cell proliferation through increased MMP activity and by supplying growth-promoting factors. Boosting mast cell recruitment and activation effectively promotes arteriogenesis, thereby protecting tissue from severe ischemic damage. We thus find that perivascular mast cells are central regulators of shear stress-induced arteriogenesis by orchestrating leukocyte function and growth factor/cytokine release, thus providing a therapeutic target for treatment of vascular occlusive diseases.


Asunto(s)
Células Endoteliales/metabolismo , Mastocitos/metabolismo , Mecanotransducción Celular , Neovascularización Fisiológica/genética , Neutrófilos/metabolismo , Remodelación Vascular/genética , Animales , Arterias/metabolismo , Arterias/patología , Plaquetas/citología , Plaquetas/metabolismo , Proliferación Celular , Células Endoteliales/citología , Regulación de la Expresión Génica , Miembro Posterior/irrigación sanguínea , Péptidos y Proteínas de Señalización Intercelular/genética , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Masculino , Mastocitos/citología , Metaloproteinasas de la Matriz/genética , Metaloproteinasas de la Matriz/metabolismo , Ratones , Monocitos/citología , Monocitos/metabolismo , NADPH Oxidasa 2/genética , NADPH Oxidasa 2/metabolismo , Neutrófilos/citología , Complejo GPIb-IX de Glicoproteína Plaquetaria/genética , Complejo GPIb-IX de Glicoproteína Plaquetaria/metabolismo , Proteínas Proto-Oncogénicas c-kit/genética , Proteínas Proto-Oncogénicas c-kit/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Receptores CXCR4/genética , Receptores CXCR4/metabolismo , Estrés Mecánico , Linfocitos T/citología , Linfocitos T/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/genética , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
5.
Lab Invest ; 96(8): 830-8, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27239731

RESUMEN

l-Arginine is the common substrate for nitric oxide synthases (NOS) and arginase. Whereas the contribution of NOS to collateral artery growth (arteriogenesis) has been demonstrated, the functional role of arginase remains to be elucidated and was topic of the present study. Arteriogenesis was induced in mice by ligation of the femoral artery. Laser Doppler perfusion measurements demonstrated a significant reduction in arteriogenesis in mice treated with the arginase inhibitor nor-NOHA (N(ω)-hydroxy-nor-arginine). Accompanying in vitro results on murine primary arterial endothelial cells and smooth muscle cells revealed that nor-NOHA treatment interfered with cell proliferation and resulted in increased nitrate/nitrite levels, indicative for increased NO production. Immuno-histological analyses on tissue samples demonstrated that nor-NOHA administration caused a significant reduction in M2 macrophage accumulation around growing collateral arteries. Gene expression studies on isolated growing collaterals evidenced that nor-NOHA treatment abolished the differential expression of Icam1 (intercellular adhesion molecule 1). From our data we conclude that arginase activity is essential for arteriogenesis by promoting perivascular M2 macrophage accumulation as well as arterial cell proliferation.


Asunto(s)
Arginasa/antagonistas & inhibidores , Circulación Colateral/efectos de los fármacos , Circulación Colateral/fisiología , Macrófagos/efectos de los fármacos , Neovascularización Fisiológica/efectos de los fármacos , Animales , Arginasa/fisiología , Arginina/análogos & derivados , Arginina/farmacología , Arterias/efectos de los fármacos , Arterias/crecimiento & desarrollo , Arterias/fisiología , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Circulación Colateral/genética , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Inhibidores Enzimáticos/farmacología , Expresión Génica/efectos de los fármacos , Molécula 1 de Adhesión Intercelular/genética , Macrófagos/citología , Masculino , Ratones , Ratones Endogámicos C57BL , Miocitos del Músculo Liso/citología , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/metabolismo , Óxido Nítrico/biosíntesis
6.
Yeast ; 27(1): 1-9, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19908204

RESUMEN

AU-rich elements (AREs) are located in the 3' untranslated region (3' UTR) of their host genes and tightly regulate mRNA degradation and expression. Examples for this kind of regulation are the human proto-oncogene c-fos and the cytokine TNFalpha. Despite large effort in this field, the exact mechanism of ARE-mediated mRNA turnover remains unclear. In this work we analysed the effects of c-fos- and TNFalpha AREs on mRNA abundance and protein expression of selected human cDNAs in the yeast Pichia pastoris. This yeast is exceedingly well known for its excellent protein production capacity; however, ARE-like mechanisms have not been studied in this yeast to date. Interestingly, we observed both stabilizing and destabilizing effects of the c-fos ARE, whereas the TNFalpha ARE has a destabilizing or expression-reducing function in all tested cDNAs. Based on this observation, we introduced a number of single-point mutations upstream of the introduced c-fos ARE into the 3' UTR of a single cDNA in order to demonstrate the importance of ARE-flanking sequences for their own regulation. In conclusion, we illustrate that the analysis of ARE-mediated effects on mRNA abundance and protein expression of a reporter depends on the sequence of the reporter itself as well as the ARE-surrounding sequences within the 3' UTR. For this reason, we question whether already established reporter constructs in other cellular systems display the true type of regulation of the tested AREs for its original host gene. Finally, we propose that AREs should be analysed in their native sequence context.


Asunto(s)
Proteínas Fúngicas/metabolismo , Regulación de la Expresión Génica/fisiología , Pichia/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , ARN Mensajero/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adenina , Proteínas Fúngicas/genética , Genes Reporteros/fisiología , Humanos , Pichia/genética , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-fos/genética , ARN Mensajero/genética , Factor de Necrosis Tumoral alfa/genética , Uracilo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...